Evidence map›Paper›PMID 37851920›Full record

ArticleACS synthetic biology2023

Maximizing Heterologous Expression of Engineered Type I Polyketide Synthases: Investigating Codon Optimization Strategies.

Matthias Schmidt, Namil Lee, Chunjun Zhan, Jacob B Roberts, Alberto A Nava, Leah S Keiser, Aaron A Vilchez, Yan Chen, Christopher J Petzold, Robert W Haushalter and 2 more

Open access · hybridAbstract read
In one paragraph

Article in ACS synthetic biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Glyceraldehyde-3-phosphate dehydrogenase homologs as bifunctional gatekeepers of metabolic segregation inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Engineered Membrane Vesicle Production viaACS synthetic biology · 2025
    Article
  15. EngineeringMetabolic engineering communications · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Matthias SchmidtJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Namil LeeJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Chunjun ZhanJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Jacob B RobertsJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Alberto A NavaJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.ORCID 0000-0002-0172-4145
Leah S KeiserJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Aaron A VilchezJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.ORCID 0009-0005-3847-189X
Yan ChenJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Christopher J PetzoldJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.ORCID 0000-0002-8270-5228
Robert W HaushalterJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.
Lars M BlankInstitute of Applied Microbiology (iAMB), Aachen Biology and Biotechnology (ABBt), RWTH Aachen University, 52062 Aachen, Germany.ORCID 0000-0003-0961-4976
Jay D KeaslingJoint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, United States.ORCID 0000-0003-4170-6088
Lawrence Berkeley National Laboratory · USQB3 · USRWTH Aachen University · DE

Funding

MINORITY PREDOCTORAL FELLOWSHIP PROGRAMF31AG005577 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI GABALDON, ANNETTE M · 1991 to 1995
–
NIA NIH HHS F31 AG005577
6 · The paper itself

Abstract

Type I polyketide synthases (T1PKSs) hold enormous potential as a rational production platform for the biosynthesis of specialty chemicals. However, despite great progress in this field, the heterologous expression of PKSs remains a major challenge. One of the first measures to improve heterologous gene expression can be codon optimization. Although controversial, choosing the wrong codon optimization strategy can have detrimental effects on the protein and product levels. In this study, we analyzed 11 different codon variants of an engineered T1PKS and investigated in a systematic approach their influence on heterologous expression in

Indexed as

PolyketidesPolyketide SynthasesCodonCodonPolyketidesPolyketide Synthasescodon optimizationcodon usageheterologous expressionindustrial hostonline tooltype 1 polyketide synthase

Identifiers

PMID37851920
PMCPMC10661030
OpenAlexW4387736023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.